Early Recognition of Overweight Hyperglycaemia May Improve Clinical Outcomes in Type 2 Diabetes.

Autor:	Chockalingam A; Division of Cardiovascular Medicine, University of Missouri, Columbia, MO, USA.; Cardiology Section, Harry S Truman VA Medical Center, Columbia, MO, USA., Natarajan P; Nova IVF Fertility, Chettinad Super Speciality Hospital (Retired), Chennai, India., Dorairajan S; Nephrology Section, Harry S Truman VA Medical Center, Columbia, MO, USA., Khan U; Division of Endocrinology, University of Missouri, Columbia, MO, USA.
Jazyk:	angličtina
Zdroj:	TouchREVIEWS in endocrinology [touchREV Endocrinol] 2023 May; Vol. 19 (1), pp. 33-37. Date of Electronic Publication: 2023 Mar 27.
DOI:	10.17925/EE.2023.19.1.33
Abstrakt:	Diabetes is the ninth leading cause of death, directly accounting for 1.5 million deaths annually worldwide. Despite several breakthrough discoveries, little progress has been made in type 2 diabetes outcomes over the past 100 years. Younger age (below 60 years), a diet high in calories and processed food, and severe obesity (body mass index >35 kg/m 2 ) may identify reversible beta cell dysfunction. Much of the clinical presentation pertains to flooding the body's adaptive limits with overnutrition. Recognizing this as a global societal trend brought about by lifestyle changes, sedentary work, mental stress and unlimited access to calorie-dense foods is crucial. Insulin resistance and genetic abnormalities cannot account for the dramatic increase in diabetes, from only 1% five decades ago to nearly 10% today. Obesity - and not insulin resistance - is at the core of the problem. As well as hyperglycaemia, end-organ damage can also be reversed with diet and weight loss in many affected individuals. We present the evolution of our understanding and compelling reasons to reframe diabetes in the severely obese to what it really is - overweight hyperglycaemia. This may shift societal perception, governmental funding, workplace reformations and individual engagement with healthy lifestyles. The objective of this review is to better understand global trends and the potential to improve outcomes by reframing the diabetes narrative towards remission. This may shift societal perception, governmental funding, workplace reformations and individual engagement with healthy lifestyles. Competing Interests: Disclosures: Anand Chockalingam is founder of www.HiLifeJourney.org, a non-profit online self-help tool aimed at improving cardiac health and resilience through self-i nquiry, and author of Seeking HUNGER, a book encouraging self-i nquiry for holistic health. He is also an advisor at the Cardiac Wellness Institute, Chennai, India. Pandiyan Natarajanb, Smrita Dorairajanc and Uzma Khan have no financial or non-financial relationships or activities to declare in relation to this article. (© Touch Medical Media 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu